Join
Live feed
·
INSIDERFilingvia Quantisnow
Immuneering Corporation logo

Director Schall Thomas J. bought $89,278 worth of shares (40,485 units at $2.21), increasing direct ownership by 1,396% to 43,385 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMRX (Immuneering Corporation) and more on Quantisnow.